Downregulation of NKD1 in human osteosarcoma and its clinical significance

Xiang Chen1, Ping Xu2, Jianwei Zhu1

  • 1Department of Orthopedics, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China.

Insights

Naked cuticle homolog 1 (NKD1) is downregulated in osteosarcoma, correlating with metastasis and advanced stage. Restoring NKD1 inhibits cancer cell growth and migration by suppressing the Wnt/β‑catenin pathway, suggesting NKD1 as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Naked cuticle homolog 1 (NKD1) negatively regulates the Wnt/β‑catenin pathway and is expressed in normal tissues.
  • Limited data exists on NKD1 expression and its role in human osteosarcoma.

Purpose of the Study:

  • To investigate NKD1 expression levels in osteosarcoma.
  • To determine the clinicopathological significance of NKD1 in osteosarcoma.
  • To explore the functional role of NKD1 in osteosarcoma cell proliferation and migration.

Main Methods:

  • Western blotting and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) were used to measure NKD1 mRNA and protein expression.
  • NKD1 was overexpressed in MG63 osteosarcoma cells using adenovirus transfection.
  • Expression of β‑catenin, cyclin D1, and MMP‑9 was assessed following NKD1 upregulation.

Main Results:

  • NKD1 expression was significantly lower in osteosarcoma tissues than in normal bone.
  • Reduced NKD1 levels correlated with lung metastasis and higher Enneking stage.
  • Overexpression of NKD1 in MG63 cells inhibited cell proliferation and migration.
  • Upregulated NKD1 suppressed β‑catenin, cyclin D1, and MMP‑9 protein expression.

Conclusions:

  • Downregulation of NKD1 is associated with osteosarcoma progression, metastasis, and staging.
  • NKD1 inactivation may promote osteosarcoma via Wnt/β‑catenin pathway activation.
  • NKD1 represents a potential prognostic biomarker and therapeutic target for osteosarcoma.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.7K